Notably, elevated salivary sCD163 concentrations in PBC patients correlate with alterations in the oral microbiome, suggesting a potential mechanistic link between oral microbial dysbiosis, macrophage activation, and enhanced local or systemic inflammation, thereby providing novel insights into PBC pathogenesis [83]. This evidence concerns the gene CD163 and primary biliary cholangitis.